Fiera Capital (Canada)
PBYI icon

Fiera Capital (Canada)’s Puma Biotechnology PBYI Stock Holding History

Fiera Capital (Canada)’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,800
Closed -$232K – 786
2016
Q2 		$232K Buy
+7,800
New +$244K ﹤0.01% 713
2016
Q1 		– Sell
-3,200
Closed -$251K – 607
2015
Q4 		$251K Buy
+3,200
New +$251K ﹤0.01% 536

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Fiera Capital (Canada)'s PBYI Position: Q3 2016 in Review

Fiera Capital (Canada) sold out of Puma Biotechnology (PBYI) in Q3 2016, closing a stake of 7,800 shares — an estimated $232K sold.

Fiera Capital (Canada) first reported a position in PBYI in Q4 2015 and held it in 2 quarters. The position peaked at $251K in Q4 2015. 149 funds tracked by Wall St. Rank hold PBYI as of Q3 2016.

  • Fiera Capital (Canada) reported no remaining Puma Biotechnology position as of Q3 2016 after selling out during the quarter.
  • Fiera Capital (Canada) sold 7,800 Puma Biotechnology shares in Q3 2016, an estimated $232K.
  • Fiera Capital (Canada) first reported a position in Puma Biotechnology in Q4 2015 and held it in 2 quarters.
  • Fiera Capital (Canada)'s Puma Biotechnology position peaked at $251K in Q4 2015.
  • 149 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2016.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2016, filed 15 Nov 2016.